36
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Acid inhibitory characteristics of omeprazole in man

, , &
Pages 105-112 | Published online: 08 Jul 2009

References

  • Larsson H, Carlsson E, Junggren U, et al. Inhibition of gastic acid secretion by omeprazole in the dog and rat. Gastroenterology 1983; 85: 900–7
  • Lind T, Cederberg C, Ekenved G, Haglund U, Olbe L. Effect of omeprazole—a gastric proton pump inhibitor on pentagastrin stimulated acid secretion in man. Gut 1983; 24: 270–6
  • Londong W, Londong V, Cederberg C, Steffen H. Dose-response study of omeprazole on mealstimulated gastric acid secretion and gastrin release. Gastroenterology 1983; 85: 1373–8
  • Konturek S J, Kweicien N, Obtulowicz W, Kopp B, Oleksy J. Action of omeprazole (a benzimidazole derivative) on secretory responses to sham feeding and pentagastrin and upon serum gastrin and pancreatic polypeptide in duodenal ulcer patients. Gut 1984; 25: 14–8
  • Howden C W, Reid J L, Forrest J AM. Effect of omeprazole on gastric acid secretion in human volunteers. Gut 1983; 24: A498
  • Dammann H G, Müller P, Seitz H K, Simon B. Säurasekretionsverhalten unten einer mehrtagigen Omeprazole-Gabe. Schweiz Med Wochenschr 1983; 113: 895–8
  • Prichard P J, Mihaly G W, Jones D B, Yeomans N D, Louis W J, Smallwood R A. Omeprazole—its oral pharmacokinetics. Br J Clin Pharmacol 1984; 17: 612P–3P
  • Daly M J, Howe A L, Misiewicz J J, et al. Omeprazole in duodenal ulcer disease: tolerance, acid inhibition, and endoscopic healing. Gut 1983; 24: A1002
  • Sharma B K, Walt R P, Pounder R P, de Gomes M FA, Wood E C, Logan L H. Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity. Gut 1984; 25: 957–64
  • Naesdal J, Bodemar G, Walan A. Effect of omeprazole, a substituted benzimidazole, on 24 hour intragastric acidity in patients with peptic ulcer disease. Scand J Gastroenterol 1984; 19: 916–22
  • Festen H PM, Thijs J C, Lamers C BHW, et al. The effect of oral omeprazole on serum gastrin and serum pepsinogen I levels. Gastroenterology 1984; 87: 1030–4

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.